CUSIP: 03842B101
Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,159,380
-
Share change
-
-1,163,006
-
Total reported value
-
$300,247,000
-
Price per share
-
$14.19
-
Number of holders
-
43
-
Value change
-
-$16,315,611
-
Number of buys
-
29
-
Number of sells
-
8
Quarterly Holders Quick Answers
What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2017
-
Previous quarter:
Q2 2017
Recent filing periods for CUSIP 03842B101:
Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q3 2017
As of 30 Sep 2017,
AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,159,380 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, Ghost Tree Capital, LLC, Boxer Capital, LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
43
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.